Domo, Inc.
NASDAQ:DOMOSoftware - Application
+$0.43 today
- Market cap
- $155.39M
- Beta
- 1.77
- P/E (TTM)
- -1.9
- EPS (TTM)
- -$1.28
Volume 3.18M
Average 1.39M
DOMO Selling, General & Admin
Overhead costs of running the business, including sales, marketing, management, and administrative staff.
Domo, Inc.NASDAQ: DOMO
Selling, General & Admin · Q1 FY2027 · quarter ended Apr 2026
Selling, general & admin declines year over year
Q1 FY2027 selling, general & admin of $50.86M fell 5.5% year over year, behind the -2.3% change in trailing-twelve-month selling, general & admin. Sequentially, it fell 3.1% from the prior quarter. Over 3 fiscal years it compounded at -4.3% a year.
Context
- Selling, general & admin amounted to 63.0% of revenue in FY2026, down 2.2 pp from a year earlier.
- Selling, general & admin increased in 0 of the last 3 fiscal years.
- FY2026 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether selling, general & admin reaches the consensus estimate from 1 analysts of $216.82M (+7.9%) for the fiscal year ending Jan 2027, a step up from the -2.8% reported in FY2026.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterApr 2026
- $50.86M-3.1% QoQ
- Last fiscal yearJan 2026
- $201.03M-2.8% YoY
- LTMApr 2026
- $198.06M-2.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -5.5% | +12.8% | +18.3 pp |
| 1 year | -2.8% | +7.9% | +10.7 pp |
| 3-year CAGR | -4.3% | -2.7% | +1.6 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Selling, General & Admin history
USD · from the income statement
- Latest · FY2026
- 201.03M USD
- Year-over-year change
- -2.8%
- 4-year CAGR
- +0.3%
| Period | Period end | Selling, General & Admin | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-31 | 201.03M | -2.8% |
| FY2025 | 2025-01-31 | 206.83M | -3.1% |
| FY2024 | 2024-01-31 | 213.35M | -7.0% |
| FY2023 | 2023-01-31 | 229.35M | +15.7% |
| FY2022 | 2022-01-31 | 198.26M | — |
Selling, General & Admin vs competitors
How DOMO compares with its peers on the latest reported figures
- Peers report in different currencies, so selling, general & admin is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -2.3% is the 8th highest of 11, against a peer median of +11.5%.
- Selling, general & admin amounts to 62.3% of revenue for DOMO, versus a peer median of 45.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $297.01M USD | +5.9% | +17.3% | 63.2% | |
| LTM Mar 2026 | $266.66M USD | -22.7% | -12.8% | 28.6% | |
| LTM Mar 2026 | $200.12M USD | -14.9% | -2.7% | 35.4% | |
| LTM Apr 2026 | $198.06M USD | -2.3% | -4.3% | 62.3% | |
| LTM Mar 2026 | $162.92M USD | +13.4% | +13.7% | 65.5% | |
| LTM Mar 2026 | $93.8M USD | +40.6% | -1.5% | 31.0% | |
| LTM Mar 2026 | $67.58M USD | -7.8% | +4.0% | 45.1% | |
| LTM Mar 2026 | $42.42M USD | +77.4% | — | 105.1% | |
| FY2025 | $34.94M USD | +9.7% | -14.2% | 6592.6% | |
NBPNovaBridge Biosciences | LTM Sep 2025 | CN¥21.46M CNY | +128.2% | -71.8% | — |
| LTM Mar 2026 | $15.92M USD | +129.9% | +9.4% | 16.9% | |
| Peer median (excluding DOMO) | — | +11.5% | -1.5% | 45.1% | |
Competitors are the stored peer set for DOMO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Jan 2022 | FY2023 Jan 2023 | FY2024 Jan 2024 | FY2025 Jan 2025 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Revenue | 257.96M | 308.65M | 318.99M | 317.04M | 318.86M |
| Cost of Revenue | 67.15M | 73.08M | 75.47M | 80.99M | 79.74M |
| Gross Profit | 190.82M | 235.57M | 243.52M | 236.05M | 239.12M |
| Gross Margin | 74.0% | 76.3% | 76.3% | 74.5% | 75.0% |
| Research & Development | 81.03M | 95.09M | 85.05M | 87.9M | 77.19M |
| Selling, General & Admin | 198.26M | 229.35M | 213.35M | 206.83M | 201.03M |
| Operating Expenses | 279.29M | 324.44M | 298.4M | 295.33M | 278.22M |
| Depreciation & Amortization | 5.36M | 5.29M | 6.62M | 9.24M | 28.75M |
| EBITDA | (83.11M) | (82.96M) | (47.51M) | (51.69M) | (28.84M) |
| EBITDA Margin | -32.2% | -26.9% | -14.9% | -16.3% | -9.0% |
| Operating Income | (88.47M) | (88.87M) | (54.88M) | (59.28M) | (39.1M) |
| Operating Margin | -34.3% | -28.8% | -17.2% | -18.7% | -12.3% |
| Interest Income | 13.4M | 15.5M | 0 | 0 | 0 |
| Interest Expense | 14.1M | 15.5M | 0 | 19.8M | 0 |
| Other Income / Expenses | (14.1M) | (15.5M) | (19.43M) | (21.44M) | (18.49M) |
| Income Before Tax | (102.57M) | (104.37M) | (74.31M) | (80.73M) | (57.58M) |
| Pre-Tax Margin | -39.8% | -33.8% | -23.3% | -25.5% | -18.1% |
| Income Tax Expense | (461K) | 1.18M | 1.26M | 1.21M | 1.76M |
| Net Income | (102.11M) | (105.55M) | (75.57M) | (81.94M) | (59.34M) |
| Net Margin | -39.6% | -34.2% | -23.7% | -25.8% | -18.6% |
| EPS (Basic) | (3.19) | (3.10) | (2.10) | (2.13) | (1.45) |
| EPS (Diluted) | (3.19) | (3.10) | (2.10) | (2.13) | (1.45) |
| Weighted Avg Shares | 32.02M | 34.09M | 36.05M | 38.5M | 40.98M |
| Weighted Avg Shares (Diluted) | 32.02M | 34.09M | 36.05M | 38.5M | 40.98M |
Domo, Inc.
NASDAQ:DOMO
Intrinsic Alpha fair value
Locked
Current Price
$3.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.